These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 576150)
1. LaVeen continuous peritoneal-jugular shunt. Improvement of renal function in ascitic patients. Wapnick S; Grosberg S; Kinney M; LeVeen HH JAMA; 1977 Jan; 237(2):131-3. PubMed ID: 576150 [TBL] [Abstract][Full Text] [Related]
2. A retrospective comparison of functional renal failure in cirrhosis treated by conventional therapy or the peritoneo-venous shunt (LeVeen). Grosberg SJ; Wapnick S Am J Med Sci; 1978; 276(3):287-91. PubMed ID: 742636 [TBL] [Abstract][Full Text] [Related]
3. Renal failure in ascites secondary to hepatic, renal, and pancreatic disease. Treatment with a LeVeen peritoneovenous shunt. Wapnick S; Grosberg S; Kinney M; Azzara V; LeVeen HH Arch Surg; 1978 May; 113(5):581-5. PubMed ID: 646616 [TBL] [Abstract][Full Text] [Related]
4. Peritoneovenous (LeVeen) shunt. Control of renin-aldosterone system in cirrhotic ascites. Witte MH; Witte CL; Jacobs S; Kut R JAMA; 1978 Jan; 239(1):31-3. PubMed ID: 579228 [TBL] [Abstract][Full Text] [Related]
5. [The peritoneo-venous shunt. A new approach in the treatment of cirrhotic "intractable" ascites (author's transl)]. Van Waes L; Maurau R; Demeulenaere L Acta Gastroenterol Belg; 1978; 41(3-4):130-8. PubMed ID: 80094 [No Abstract] [Full Text] [Related]
6. The 'hepatorenal' syndrome and refractory ascites. Successful therapy with the LeVeen-type peritoneal-venous shunt and valve. Kinney MJ; Schneider A; Wapnick S; Grosberg S; LeVeen H Nephron; 1979; 23(5):228-32. PubMed ID: 481657 [No Abstract] [Full Text] [Related]
7. A test for evaluation of peritoneo-venous shunt function: concise communication. Gorten RJ J Nucl Med; 1977 Jan; 18(1):29-31. PubMed ID: 830824 [TBL] [Abstract][Full Text] [Related]
9. Peritoneo-jugular (LeVeen) shunt for treatment of ascites. Garred JL J Iowa Med Soc; 1978 Aug; 68(8):284-6. PubMed ID: 690490 [No Abstract] [Full Text] [Related]
10. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Wong F; Pantea L; Sniderman K Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086 [TBL] [Abstract][Full Text] [Related]
11. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397 [TBL] [Abstract][Full Text] [Related]
16. Indications for peritoneo-jugular shunt for ascites. LeVeen HH; Wapnick S; Guinto R; Kinney M World J Surg; 1978 May; 2(3):367-71. PubMed ID: 706426 [No Abstract] [Full Text] [Related]
17. Peritoneovenous shunting for ascites. Reinhardt GF; Stanley MM Surg Gynecol Obstet; 1977 Sep; 145(3):419-24. PubMed ID: 888064 [TBL] [Abstract][Full Text] [Related]
18. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219 [TBL] [Abstract][Full Text] [Related]
19. Assessment of peritoneojugular shunts by direct roentgenographic examination. Ring EJ; Rosato EF Surg Gynecol Obstet; 1979 Jan; 148(1):93-4. PubMed ID: 758707 [TBL] [Abstract][Full Text] [Related]
20. Cervical lymphato-venous shunt in treatment of ascites in caval-constricted dogs and in patients with hepatic cirrhosis. Experimental observations and 7 years clinical experience. Serényi P; Magyar Z; Szabó G Lymphology; 1976 Jun; 9(2):53-61. PubMed ID: 957766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]